Italian Study Examines Tysabri and Risk for Miscarriage and Birth Defects
Multiple Sclerosis News
Publication date: Feb 14, 2018 Pregnant women with multiple sclerosis (MS) exposed to Tysabri (natalizumab) in the first trimester had higher rates of miscarriage and major birth defects in their ... Read more